CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, July 29th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...